Leuprolide recalls

The FDA has published 6 recalls involving Leuprolide since 2014. The latest was reported on 4 Oct 2023. AbbVie has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls6since 2014
Last 12 months0reported
Class I00% of total
Ongoing0latest 4 Oct 2023

Recalls per month, last 24 months

click a bar for that month

Severity split

Class I 0 0%Class II 5 83%Class III 1 17%

Why leuprolide is recalled

Companies

By year

All leuprolide recalls, newest first

6 total
ReportedClassRecallCompanyReasonWhere
DrugCLASS IIIEligard (leuprolide acetate) for injectable suspension recalledEligardTolmarSterilityNationwide
DrugCLASS IILupron Depot (Leuprolide Acetate recalled by AbbVieLupron DepotAbbVieOtherNationwide
DrugCLASS IILupron Depot-ped (Leuprolide Acetate recalled by AbbVieLupron Depot-pedAbbVieOtherNationwide
DrugCLASS IILupron Depot (leuprolide acetate recalled by AbbVieLupron DepotAbbVieOtherNationwide
DrugCLASS IILupron Depot (Leuprolide Acetate recalled by AbbVieLupron DepotAbbVieOtherNationwide
DrugCLASS IILupron Depot (Leuprolide Acetate recalled by AbbVieLupron DepotAbbVieOtherNationwide

Should you stop taking Leuprolide?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.